Brief: Bellerophon Therapeutics Q1 Loss Per Share $0.58
11/05/2021 13:39
May 11 (Reuters) - Bellerophon Therapeutics Inc BLPH.O :
* BELLEROPHON PROVIDES CLINICAL PROGRAM UPDATE AND REPORTS
FIRST
QUARTER 2021 FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.58
* AS OF MARCH 31, 2021, COMPANY HAD CASH AND CASH
EQUIVALENTS OF
$39.7 MILLION
Source text for Eikon: ID:nGNX1PTpMX
Further company coverage: BLPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen